FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1894320934> ?p ?o ?g. }

• W1894320934 abstract "The prokaryotic CRISPR (clustered regularly interspaced short palindromic repeat)-Cas9, an RNA-guided endonuclease, has been shown to mediate efficient genome editing in a wide variety of organisms. In the present study, the CRISPR-Cas9 system has been adapted to Leishmania donovani, a protozoan parasite that causes fatal human visceral leishmaniasis. We introduced the Cas9 nuclease into L. donovani and generated guide RNA (gRNA) expression vectors by using the L. donovani rRNA promoter and the hepatitis delta virus (HDV) ribozyme. It is demonstrated within that L. donovani mainly used homology-directed repair (HDR) and microhomology-mediated end joining (MMEJ) to repair the Cas9 nuclease-created double-strand DNA break (DSB). The nonhomologous end-joining (NHEJ) pathway appears to be absent in L. donovani. With this CRISPR-Cas9 system, it was possible to generate knockouts without selection by insertion of an oligonucleotide donor with stop codons and 25-nucleotide homology arms into the Cas9 cleavage site. Likewise, we disrupted and precisely tagged endogenous genes by inserting a bleomycin drug selection marker and GFP gene into the Cas9 cleavage site. With the use of Hammerhead and HDV ribozymes, a double-gRNA expression vector that further improved gene-targeting efficiency was developed, and it was used to make precise deletion of the 3-kb miltefosine transporter gene (LdMT). In addition, this study identified a novel single point mutation caused by CRISPR-Cas9 in LdMT (M381T) that led to miltefosine resistance, a concern for the only available oral antileishmanial drug. Together, these results demonstrate that the CRISPR-Cas9 system represents an effective genome engineering tool for L. donovani.Leishmania donovani is the causative agent of fatal visceral leishmaniasis. To understand Leishmania infection and pathogenesis and identify new drug targets for control of leishmaniasis, more-efficient ways to manipulate this parasite genome are required. In this study, we have implemented CRISPR-Cas9 genome-editing technology in L. donovani. Both single- and dual-gRNA expression vectors were developed using a strong RNA polymerase I promoter and ribozymes. With this system, it was possible to generate loss-of-function insertion and deletion mutations and introduce drug selection markers and the GFP sequence precisely into the L. donovani genome. These methods greatly improved the ability to manipulate this parasite genome and will help pave the way for high-throughput functional analysis of Leishmania genes. This study further revealed that double-stranded DNA breaks created by CRISPR-Cas9 were repaired by the homology-directed repair (HDR) pathway and microhomology-mediated end joining (MMEJ) in Leishmania." @default.
• W1894320934 created "2016-06-24" @default.
• W1894320934 creator A5082082356 @default.
• W1894320934 creator A5089387183 @default.
• W1894320934 date "2015-09-01" @default.
• W1894320934 modified "2023-09-27" @default.
• W1894320934 title "CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani" @default.
• W1894320934 cites W1731173485 @default.
• W1894320934 cites W1967058514 @default.
• W1894320934 cites W1968342623 @default.
• W1894320934 cites W1973260880 @default.
• W1894320934 cites W1973895107 @default.
• W1894320934 cites W1982846895 @default.
• W1894320934 cites W1985394274 @default.
• W1894320934 cites W1989840144 @default.
• W1894320934 cites W1992783297 @default.
• W1894320934 cites W1997509018 @default.
• W1894320934 cites W2001082479 @default.
• W1894320934 cites W2007818617 @default.
• W1894320934 cites W2019461837 @default.
• W1894320934 cites W2036386073 @default.
• W1894320934 cites W2039502062 @default.
• W1894320934 cites W2041502642 @default.
• W1894320934 cites W2043275428 @default.
• W1894320934 cites W2043369680 @default.
• W1894320934 cites W2045435533 @default.
• W1894320934 cites W2050480410 @default.
• W1894320934 cites W2051088451 @default.
• W1894320934 cites W2052532553 @default.
• W1894320934 cites W2055730063 @default.
• W1894320934 cites W2058438089 @default.
• W1894320934 cites W2062016511 @default.
• W1894320934 cites W2064815984 @default.
• W1894320934 cites W2065503544 @default.
• W1894320934 cites W2074543807 @default.
• W1894320934 cites W2083431317 @default.
• W1894320934 cites W2083943161 @default.
• W1894320934 cites W2092682261 @default.
• W1894320934 cites W2094948776 @default.
• W1894320934 cites W2096261947 @default.
• W1894320934 cites W2096384918 @default.
• W1894320934 cites W2097344907 @default.
• W1894320934 cites W2102565252 @default.
• W1894320934 cites W2107647128 @default.
• W1894320934 cites W2107915297 @default.
• W1894320934 cites W2107959600 @default.
• W1894320934 cites W2114773348 @default.
• W1894320934 cites W2116254072 @default.
• W1894320934 cites W2119018101 @default.
• W1894320934 cites W2119799023 @default.
• W1894320934 cites W2125112712 @default.
• W1894320934 cites W2132920733 @default.
• W1894320934 cites W2140341433 @default.
• W1894320934 cites W2144120140 @default.
• W1894320934 cites W2147828217 @default.
• W1894320934 cites W2148023527 @default.
• W1894320934 cites W2148413234 @default.
• W1894320934 cites W2163248265 @default.
• W1894320934 cites W2163938277 @default.
• W1894320934 cites W2170039745 @default.
• W1894320934 cites W2170302951 @default.
• W1894320934 cites W2171530398 @default.
• W1894320934 cites W2171730432 @default.
• W1894320934 cites W2397184954 @default.
• W1894320934 cites W262452561 @default.
• W1894320934 doi "https://doi.org/10.1128/mbio.00861-15" @default.
• W1894320934 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4513079" @default.
• W1894320934 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26199327" @default.
• W1894320934 hasPublicationYear "2015" @default.
• W1894320934 type Work @default.
• W1894320934 sameAs 1894320934 @default.
• W1894320934 citedByCount "143" @default.
• W1894320934 countsByYear W18943209342016 @default.
• W1894320934 countsByYear W18943209342017 @default.
• W1894320934 countsByYear W18943209342018 @default.
• W1894320934 countsByYear W18943209342019 @default.
• W1894320934 countsByYear W18943209342020 @default.
• W1894320934 countsByYear W18943209342021 @default.
• W1894320934 countsByYear W18943209342022 @default.
• W1894320934 countsByYear W18943209342023 @default.
• W1894320934 crossrefType "journal-article" @default.
• W1894320934 hasAuthorship W1894320934A5082082356 @default.
• W1894320934 hasAuthorship W1894320934A5089387183 @default.
• W1894320934 hasBestOaLocation W18943209341 @default.
• W1894320934 hasConcept C104317684 @default.
• W1894320934 hasConcept C132455925 @default.
• W1894320934 hasConcept C144501496 @default.
• W1894320934 hasConcept C2776555147 @default.
• W1894320934 hasConcept C2778689377 @default.
• W1894320934 hasConcept C2781333301 @default.
• W1894320934 hasConcept C54355233 @default.
• W1894320934 hasConcept C70721500 @default.
• W1894320934 hasConcept C86803240 @default.
• W1894320934 hasConcept C97702854 @default.
• W1894320934 hasConcept C98108389 @default.
• W1894320934 hasConceptScore W1894320934C104317684 @default.
• W1894320934 hasConceptScore W1894320934C132455925 @default.
• W1894320934 hasConceptScore W1894320934C144501496 @default.
• W1894320934 hasConceptScore W1894320934C2776555147 @default.
• W1894320934 hasConceptScore W1894320934C2778689377 @default.

• next